5-Methyl-2-(piperidin-3-yloxy)pyridine dihydrochloride

Catalog No.: 
ACRPLP344
CAS No.: 
2060041-44-1
Molecular Formula: 
C11H18Cl2N2O
Molecular Weight: 
265.18
5-Methyl-2-(piperidin-3-yloxy)pyridine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$245.00InquiryInquiry
100mg95%$358.00InquiryInquiry
250mg95%$504.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methyl-2-(piperidin-3-yloxy)pyridine dihydrochloride
IUPAC Name5-methyl-2-(piperidin-3-yloxy)pyridine dihydrochloride
MDL No.MFCD30498007
Molecular FormulaC11H18Cl2N2O
Molecular Weight265.18
SMILESCC1=CN=C(OC2CNCCC2)C=C1.[H]Cl.[H]Cl
InChI KeyVXIKYQOBKSBITP-UHFFFAOYSA-N
Synonym5-methyl-2-(piperidin-3-yloxy)pyridine dihydrochloride
CAS No.2060041-44-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRPLP344 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJOWT087 route compound structure diagram
    ACJOWT08718368-64-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPLP344 route product structure diagram
    ACRPLP3442060041-44-1
Inquiry

2. ACRPLP344 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRPLP344 route product structure diagram
    ACRPLP3442060041-44-1
Inquiry

3. ACRPLP344 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPLP344 route product structure diagram
    ACRPLP3442060041-44-1
Inquiry

Comments (0)